Neuroendocrinological study of opioid and serotoninergic systems in migraine patients.
PRL response to morphine in a group of migraine subjects was studied in the baseline condition and after neuroendocrinological inhibition and stimulation tests. No significant differences were found in comparison with control subjects. This demonstrated the integrity of the opioid system and serotoninergic pathways in migraine subjects.
D000328:Adult; D001921:Brain / Q000503:physiopathology*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008711:Metergoline; D008881:Migraine Disorders / Q000503:physiopathology*; D009020:Morphine; D009270:Naloxone; D010918:Pizotyline; D011388:Prolactin / Q000378:metabolism*; D011957:Receptors, Opioid / Q000502:physiology*; D012701:Serotonin / Q000502:physiology*
D011957:Receptors, Opioid; D010918:Pizotyline; D008711:Metergoline; D012701:Serotonin; D009270:Naloxone; D009020:Morphine; D011388:Prolactin